pitavastatin aldehyde imp

Pitavastatin aldehyde imp is a degradation byproduct formed via oxidative cleavage of the pyrroline ring in pitavastatin, introducing an aldehyde functional group at the C-2 position. This impurity retains the core HMG-CoA reductase inhibitor scaffold, featuring a 2-(4-fluorophenyl)ethyl moiety and a 5-(1-methylethyl)-3-pyrroline backbone, with the aldehyde substituent altering the parent compound's hydrogen bonding capacity and hydrophilicity. It arises during forced degradation studies under oxidative stress, serving as a critical HPLC reference standard for impurity profiling in pitavastatin drug substance analysis.